Effect of family health management on type 2 diabetes medication adherence of patients in commuhity
10.3760/cma.j.issn.1674-0815.2014.05.006
- VernacularTitle:家庭健康管理对社区2型糖尿病患者服药依从性影响的研究
- Author:
Ping LU
;
Wenyan MA
- Publication Type:Journal Article
- Keywords:
Diabetes mellitus,type 2;
Medication adherence;
Health management
- From:
Chinese Journal of Health Management
2014;8(5):301-304
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the effect of family health management on community type 2 diabetes medication compliance.Methods Totally 123 patients with type 2 diabetes who live in Shanghai City Qingpu District Xujing Town An Ju Wei Hao Xiao Qu and met the WHO diagnostic criteria for type 2 diabetes were enrolled into this study.The patients' age was 50-75 years,including 60 male,63 female cases,mean age was (63.9 ± 6.9),(10.0 ± 7.4) years,course of disease,a family health file,making personalized home health management measures of community were analyzed.The effects of the 2 years of intervention on the compliance of the patients before and after the intervention as well as the blood pressure,blood glucose,blood lipid control were evaluated.Results The treatment compliance rate was (77.1％,94/122,intervention 1 cases died) significantly higher after intervention than that before intervention (62.6％,77/123) (x2=6.06,P＜0.05).After the intervention,the rate of target achievement in blood pressure (51.6％,63/122),blood glueose (44.3％,54/122),total cholesterol (72.1％,88/122),triglyceride (61.5％,75/122) low density lipoprotein (75.4％,92/122) were higher than those before intervention [blood pressure standard rate of 36.6％ (45/123),blood glucose standard rate of 28.5％ (35/123),total cholesterol standard rate of 59.3％ (73/123),triglyceride standard rate of 47.9％ (59/123),low density lipoprotein standard rate of 65.0％ (80/123)],the differences were statistically significant (x2=5.63,6.61,4.44,4.51,3.97,P＜0.05).Conclusion Community and family health management can improve the medication compliance in patients with type 2 diabetes.
